https://www.selleckchem.com/products/Ki16425.html
In SFY 2018, the developmental screening percentage at non-ROR sites was 33% vs 47% at ROR sites (p less then 0.0001), in SFY 2019 non-ROR sites were 36% vs 48% at ROR sites (p less then 0.0001). The EPSDT visit percentage in SFY 2018 was 50% at non-ROR sites vs 69% at ROR sites and in SFY 2019 was 51% at non-ROR sites vs 72% at ROR sites. HSIs are an effective way to fund ROR. Additional funding allowed for increased ROR sites and training. ROR sites are more likely to perform developmental screenings and EPSDT visits.This study compar
Like
Comment
Share
